NCT00958009View on ClinicalTrials.gov

The Multicenter, Open-label, Single-use Autoinjector Convenience Study

PHASE3CompletedINTERVENTIONAL
Enrollment

109

Participants

Timeline

Start Date

October 31, 2009

Primary Completion Date

April 30, 2010

Study Completion Date

June 30, 2010

Conditions
Multiple Sclerosis
Interventions
DEVICE

Rebidose®

The device is a ready to use single use auto injector containing Rebif® 44 mcg in a 0.5 mL prefilled syringe for sc injection

Trial Locations (1)

02370

EMD Serono, Inc., Rockland

Sponsors

Lead Sponsor

EMD Serono
All Listed Sponsors
lead

EMD Serono

INDUSTRY

NCT00958009 - The Multicenter, Open-label, Single-use Autoinjector Convenience Study | Biotech Hunter | Biotech Hunter